Solid Biosciences (SLDB) Interest Expenses (2017 - 2026)

Solid Biosciences (SLDB) has 10 years of Interest Expenses data on file, last reported at $5.4 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 3779.29% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 3779.29% YoY), and the FY2025 full-year result was $190.4 million, up 45.72% from the prior year.
• Interest Expenses grew to $5.4 million in Q1 2026, from $5000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $163.6 million in Q4 2022 to a low of $5000.0 in Q4 2025.
• A 5-year average of $10.6 million and a median of $122000.0 in 2022 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses sank 99.87% in 2025 and surged 3779.29% in 2026, its largest moves.
• Tracing SLDB's Interest Expenses over 5 years: stood at $163.6 million in 2022, then plunged by 97.46% to $4.2 million in 2023, then decreased by 3.92% to $4.0 million in 2024, then slumped by 99.87% to $5000.0 in 2025, then surged by 108520.0% to $5.4 million in 2026.
• Business Quant data shows SLDB's Interest Expenses at $5.4 million in Q1 2026, $5000.0 in Q4 2025, and $1.7 million in Q3 2025.